top of page

Pro PG receives S19A RoActemra tocilizumab 162mg/0.9mL PFS and PENS

Pro Pharmaceuticals Group has arranged for the supply of the following overseas registered tocilizumab products on a temporary basis:


RoActemra tocilizumab 162mg/0.9mL solution for injection in pre-filled syringe (Roche Germany)

RoActemra tocilizumab 162mg/0.9mL solution for injection in pre-filled pen (Roche Germany)


These products are NOT registered in Australia and supply is authorised under an exemption granted by the Therapeutic Goods Administration (TGA) under section 19A of the Therapeutic Goods Act 1989 until 28 February 2022



Please contact us for more information









 
 
Recent Posts
Archive
Search By Tags
Follow Us
  • Twitter Social Icon
  • Google+ Basic Square

TEL:

1300 077 674 (1300 0 PRO PG)

FAX:

(03) 86790397

AUSTRALIA​      |  GERMANY  |      POLAND

Pro PG and Logo are registered trademarks (EU, UK, Australia) owned by Pro Pharmaceuticals Group © 2025 Pro Pharmaceuticals Group Pty Ltd  |  All Rights Reserved

VAT: NL825524295B01 VAT: PL5263362401 VAT: DE401757398 ABN: 20605457430 

United Nations Global Marketplace (UNGM) Registered Supplier Vendor No. 1092276

bottom of page